데이터가 없습니다.

1. Age-Related Incidence and Peak Occurrence of Contralateral Breast Cancer [ Jama Network Open ] - 2023.12.01
2. Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor?Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial [ JOURNAL OF CLINICAL ONCOLOGY ] - 2023.11.01
3. Factors in Parenting Stress in Young Patients With Breast Cancer and Implications for Children's Emotional Development: The PSYCHE Study [ Jama Network Open ] - 2023.11.01
4. Survival Outcomes in Premenopausal Patients With Invasive Lobular Carcinoma [ Jama Network Open ] - 2023.11.01
5. Multidisciplinary Shared Decision Making for Fertility Preservation in Young Women With Breast Cancer [ Journal of Breast Cancer ] - 2023.10.11
6. Long-term outcome in patients with nodal-positive breast cancer treated with sentinel lymph node biopsy alone after neoadjuvant chemotherapy [ BREAST CANCER RESEARCH AND TREATMENT ] - 2023.10.05
7. Survival After Development of Contralateral Breast Cancer in Korean Patients With Breast Cancer [ Jama Network Open ] - 2023.09.05
8. Correlation of shear-wave elastography parameters with the molecular subtype and axillary lymph node status in breast cancer [ CLINICAL IMAGING ] - 2023.09.01
9. Fertility Preservation in Young Women With Breast Cancer: A Review [ 한국유방암학회지(Journal of Breast Cancer) ] - 2023.06.13
10. Breast Cancer Statistics in Korea, 2019 [ Journal of Breast Cancer ] - 2023.06.01
11. Knowledge, attitudes, and behaviors toward fertility preservation in patients with breast cancer: A cross-sectional survey of physicians [ Frontiers in Oncology ] - 2023.01.23
12. Surgical Treatment After Neoadjuvant Systemic Therapy in Young Women With Breast Cancer Results From a Prospective Cohort Study [ ANNALS OF SURGERY ] - 2022.07.01
13. Axillary Lymph Node Dissection Rates and Prognosis From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer [ FRONTIERS IN ONCOLOGY ] - 2021.09.30
14. Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer [ FRONTIERS IN ONCOLOGY ] - 2021.07.02
15. Five-year changes in ovarian function restoration in premenopausal patients with breast cancer taking tamoxifen after chemotherapy: An ASTRRA study report [ EUROPEAN JOURNAL OF CANCER ] - 2021.07.01
16. Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer [ SCIENTIFIC REPORTS ] - 2021.05.18
17. Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative, lymph node-positive breast cancer [ BREAST CANCER RESEARCH ] - 2020.05.27
18. Changes in bone mineral density during 5 years of adjuvant treatment in premenopausal breast cancer patients [ BREAST CANCER RESEARCH AND TREATMENT ] - 2020.04.01
19. Age-related risk factors associated with primary contralateral breast cancer among younger women versus older women [ BREAST CANCER RESEARCH AND TREATMENT ] - 2019.02.01
20. Characteristics and prognosis of breast cancer after liver or kidney transplantation [ BREAST CANCER RESEARCH AND TREATMENT ] - 2018.01.01
21. Survival improvement in hormone-responsive young breast cancer patients with endocrine therapy [ BREAST CANCER RESEARCH AND TREATMENT ] - 2017.09.01
22. Concurrent Gonadotropin-Releasing Hormone Agonist Administration with Chemotherapy Improves Neoadjuvant Chemotherapy Responses in Young Premenopausal Breast Cancer Patients. [ Journal of Breast Cancer ] - 2015.12.15
23. A proposal for a new classification of T4 breast cancer as stage IIIC: a report from the Korean Breast Cancer Society. [ BREAST CANCER RESEARCH AND TREATMENT ] - 2015.08.01
24. Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes. [ BREAST CANCER RESEARCH ] - 2015.05.03

1. 젊은 유방암 환자에서 가임력 보존을 위한 다학제 공동 의사 결정 - 2022.05.01 ~ 2022.12.31
2. 젊은 유방암 환자에서 가임력 보존을 위한 다학제 공동 의사 결정 - 2021.08.20 ~ 2022.04.30
3. 젊은 유방암 환자에서 가임력 보존을 위한 다학제 공동 의사 결정 - 2021.01.04 ~ 2021.08.19
4. 호르몬 치료 반응성 유방암을 진단받은 폐경 이전의 젊은 유방암 환자에서 항암치료 이후 난소 기능이 보존, 회복된 환자의 타목시펜에 난소 억제 주사제 추가치료의 장기 효과 비교 - 2020.08.20 ~ 2021.08.19
5. 호르몬 치료 반응성 유방암을 진단받은 폐경 이전의 젊은 유방암 환자에서 항암치료 이후 난소 기능이 보존, 회복된 환자의 타목시펜에 난소 억제 주사제 추가치료의 장기 효과 비교 - 2020.03.05 ~ 2020.08.19
6. 임신과 동반된 유방암 또는 유방암 이후 임신한 환자에서 circulating tumor DNA 의 유용성 - 2019.10.01 ~ 2020.12.31
7. 호르몬 수용체 음성 유방암에서 항암치료와 GnRH agonist 병합요법의 종양학적 안전성 평가 및 GnRH Receptor Score 개발 - 2016.01.01 ~ 2016.12.31

데이터가 없습니다.

      데이터가 없습니다.

 공지